This article provides an overview of solutions to address key challenges facing vaccine developers or CDMOs wishing to build their own commercial-scale mRNA production facilities.
Ranna Eardley-Patel
Advertisement
Ranna Eardley-Patel is a sustainable manufacturing lead at CEPI.
Articles by Ranna Eardley-Patel
Advertisement
Latest Updated Articles
Overcoming Engineering Challenges to Enable Commercial Scale mRNA Vaccine ManufacturingPublished: August 3rd 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
2
How AI, Machine Learning, and Large Language Models Enhance Bioanalysis
3
AAPS PharmSci 360 2025: Trends in Bioanalysis
4
PharmTech Weekly News Roundup – Week of November 3, 2025
5
